SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Board appointments

31 Mar 2014 07:00

RNS Number : 5183D
Frontier IP Group plc
31 March 2014
 



 

AIM: FIPP

 

Frontier IP Group plc

("Frontier IP" or "the Company")

 

Board changes

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce two Board appointments, which both take immediate effect. James Fish has been appointed to the Company as Finance Director and Michael Bourne has been appointed to the Company as a Non-Executive Director.

 

James Fish, a chartered accountant, has over 25 years' experience in senior financial positions and a wide range of commercial experience including venture capital funded small/medium-sized enterprises and start-up companies. He was latterly interim Finance Director at The One Place Capital Limited, an online technology start-up. He qualified as a chartered accountant with KPMG and holds a degree in Accounting and Finance from Heriot Watt University, Edinburgh. James's appointment enables Marilyn Cole to step down as Finance Director and Company Secretary. James will also be appointed Company Secretary.

 

Michael Bourne has almost 30 years' experience in investment management and particular expertise in technology, life sciences and clean technology. He is currently Partner of Accretion Capital LLP and a Director of Cygna Negra Limited and Cygna Negra Malta Limited. He is also an Advisory Board Member of V2R, the US technology transfer venture company. Prior to these roles, in 1995, he founded asset management company, Reabourne Technology Investments Limited, where he was also Chief Investment Officer. For nine years until 2009, he was also a member of the techMARK Advisory Committee.

 

Neil Crabb, Chief Executive of Frontier IP, said,

 

"We are delightedto welcome Jim as Finance Director and Mike as a Non-executive Director. Their appointments strengthen our Board as we continue Frontier IP's development.

 

Jim brings over 25 years' experience as a senior finance professional and his involvement with start-up companies as well as venture capital funded SMEs is especially useful. Mike has substantial experience in investment management and his expertise in the clean energy and life sciences sectors also represents an excellent fit with Frontier IP's activities.

 

As well as welcoming Jim and Mike, I would also like to acknowledge Marilyn's significant contribution to Frontier IP during her time as Finance Director of the Company. She leaves with the Board's best wishes and grateful thanks."

 

The following information is required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

James Milne Fish, aged 56, is or has been a director or partner of the following companies during the previous five years:

 

Current Directorships / Partnerships:

Directorships / Partnerships held within the previous five years:

FD Support Limited

 

In addition, as an interim finance director, Mr Fish has undertaken in the previous five years a finance director role with The One Place Capital Limited, McLaren Software Group Limited and Photo Therapeutics Group Limited. Photo Therapeutics Group Limited entered into a Voluntary Members Liquidation in March 2009, after the return of funds to shareholders following a trade sale of the operating subsidiary.

 

Mr Fish is a member of the Institute of Chartered Accountants of Scotland.

 

Mr Fish currently has no beneficial interest in the share capital of the Company.

 

There are no other matters which are required to be announced with regard to the appointment of Mr Fish under paragraph (g) of Schedule 2 of the AIM Rules.

 

Michael Gerald Bourne, aged 55, is or has been a director or partner of the following companies during the previous five years:

 

Current Directorships / Partnerships:

Directorships / Partnerships held within the previous five years:

Accretion Capital LLP

MGB Technology Consulting Ltd

Coombe Wood Lawn Tennis Club Limited

Cygna Negra Limited

Cygna Negra Malta Limited

 

Mr Bourne currently has no beneficial interest in the share capital of the Company.

 

There are no other matters which are required to be announced with regard to the appointment of Mr Bourne under paragraph (g) of Schedule 2 of the AIM Rules.

 

 

Enquiries

 

Frontier IP Group Plc

0131 220 9491

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

020 7894 7000

Mark Percy / Catherine Leftley, Corporate Finance

David Banks / Paul Jewell, Corporate Broking

Peterhouse Corporate Finance Limited (Joint Broker)

020 7469 0935

Jon Levinson / Lucy Williams

KTZ Communications

020 3178 6378

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IPspecialises in the commercialisation of Intellectual Property. It establishes partnerships with individual universities and research institutions to assist with their spin-out and licensing activities and helps to maximise the commercial value of technologies emerging from their research programmes. www.frontierip.co.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADVLFLZXFEBBK
Date   Source Headline
14th Sep 20157:00 amRNSHolding(s) in Company
14th Sep 20157:00 amRNSHolding(s) in Company
24th Jul 20152:18 pmRNSHolding(s) in Company
10th Jul 20158:30 amRNSHolding(s) in Company
14th Apr 20157:00 amRNSHolding(s) in Company
10th Apr 20157:00 amRNSPlacing of new shares
31st Mar 20157:00 amRNSHalf Yearly Report
25th Mar 201510:52 amRNSPortfolio company, Alusid - First Fundraising
11th Mar 20157:00 amRNSKey development at portfolio company PulsiV Solar
10th Mar 20157:03 amRNSHolding(s) in Company
9th Mar 20157:00 amRNSNew advisory client, Vertequip
2nd Mar 20157:00 amRNSNew portfolio company
9th Feb 20157:00 amRNSScottish Enterprise Awards
5th Feb 20157:00 amRNSKey developments at portfolio company Alusid
2nd Feb 20157:00 amRNSHolding(s) in Company
7th Jan 20157:00 amRNSPortfolio company Nandi Proteins featured on BBC
29th Dec 201411:44 amRNSResult of AGM
4th Dec 20147:00 amRNSPosting of Annual Report & Notice of AGM
1st Dec 20147:00 amRNSFinal Results
26th Nov 20147:00 amRNSNew spin-out company
17th Nov 20147:00 amRNSHolding(s) in Company
4th Nov 20149:52 amRNSPortfolio company collaboration agreement
3rd Nov 20147:00 amRNSFundraising for portfolio company, Nandi
8th May 20147:00 amRNSBoard Changes
3rd Apr 20143:45 pmRNSHolding(s) in Company
2nd Apr 20147:00 amRNSDirector/PDMR Shareholding
31st Mar 20147:00 amRNSBoard appointments
31st Mar 20147:00 amRNSHalf Yearly Report
30th Dec 20139:46 amRNSHolding(s) in Company
23rd Dec 20139:51 amRNSHolding(s) in Company
20th Dec 20137:00 amRNSPlacing of New Shares
4th Dec 20132:50 pmRNSResult of AGM
4th Dec 20137:00 amRNSAGM Statement
18th Nov 20133:03 pmRNSHolding(s) in Company
15th Nov 20137:00 amRNSNew spin-out company with Plymouth University
12th Nov 20134:22 pmRNSHolding(s) in Company
8th Nov 20132:43 pmRNSNotice of AGM
6th Nov 20132:21 pmRNSHolding(s) in Company
31st Oct 20137:00 amRNSFinal Results
30th Sep 20137:00 amRNSTrading update & date of results
20th Aug 20137:00 amRNSHolding(s) in Company
20th Aug 20137:00 amRNSHolding(s) in Company
19th Aug 201310:57 amRNSHolding(s) in Company
16th Aug 201310:36 amRNSHolding(s) in Company
15th Aug 20134:14 pmRNSDirector/PDMR Shareholding
15th Aug 201312:01 pmRNSHolding(s) in Company
15th Aug 201312:00 pmRNSHolding(s) in Company
14th Aug 20137:00 amRNSPlacing, share swap, Director shareholdings & TVR
26th Jul 20137:00 amRNSEnergy Sector Collaboration
8th May 20137:00 amRNSRe Portfolio Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.